Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Other Accumulated Expenses (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) reported Other Accumulated Expenses of $96,000 for Q2 2026, down 2.0% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics posted Other Accumulated Expenses of $91,000, down 30.0% from FY2024.

  • By year, Other Accumulated Expenses came in at $130,000 in FY2024.
  • Five-year quarterly Other Accumulated Expenses spans a low of $91,000 in Q4 2025 and a high of $130,000 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96,000.00
Mar 31, 2026 98,000.00
Dec 31, 2025 91,000.00
Dec 31, 2024 130,000.00
API Access

Polaryx Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PLYX&period=max&api_key=YOUR_API_KEY